A Belgian-American health start-up has launched a remote monitoring kit for vital signs.
Byteflies has developed its Exploration Kit that contains five programmable high-precision sensors dots that continuously and remotely monitor vital signs.
The wearable sensors connect to the company’s data processing platform. Byteflies is targeting pharmaceutical companies, start-ups and research groups involved in clinical studies or that developing their own wearable health applications.
The exploration kit and data platform was based on insights gained through practical use cases and decades of experience in healthcare and technology applications. It aims to tackle the growing need for better patient follow-ups, accelerated drug developments and disease insights. Byteflies state that the lack of tools and options inspired the company to build its own exploration kit and data platform.
Hans Danneels, CEO and co-founder of Byteflies, said: “Worldwide, around 46% of people suffer from a chronic condition. When it comes to monitoring their health, wearables have incredible potential. However, a wristband that counts steps and measures heart rate just won’t cut it when you’re developing solutions for Parkinson’s disease, pulmonary and cardiovascular conditions, hypertension, or epilepsy. You need to be able to measure raw, accurate data – the kind of data collected in hospitals. That’s where our solution comes in.”
Byteflies sensors can measure different vital signs, ranging from blood flow (PPG) to electro-dermal activity (EDA), electrocardiogram (ECG), motion, respiration, and electromyogram (EMG). The technology is currently being used by CWRU Cleveland, the University of Leuven (Belgium) and pharmaceutical company UCB for detection of epileptic seizures, blood pressure trends, balance, and fatigue.
“We seek to transform the entire healthcare system through our technology, leading to wearables with tangible medical relevance. Quality, a very high level of detail, and tech validation are our key concerns as we work closely with our clients.” Hans Danneels concluded.